UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000047202
Receipt No. R000053842
Scientific Title Clinical performance of TECNIS Eyhance Optiblue in combined vitrectomy and cataract surgery in patients with ERM
Date of disclosure of the study information 2022/05/01
Last modified on 2022/06/29 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical performance of TECNIS Eyhance Optiblue in combined vitrectomy and cataract surgery in patients with ERM
Acronym Clinical performance of TECNIS Eyhance Optiblue in combined vitrectomy and cataract surgery in patients with ERM
Scientific Title Clinical performance of TECNIS Eyhance Optiblue in combined vitrectomy and cataract surgery in patients with ERM
Scientific Title:Acronym Clinical performance of TECNIS Eyhance Optiblue in combined vitrectomy and cataract surgery in patients with ERM
Region
Japan

Condition
Condition cataract and epiretinal membrane
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate clinical performance of TECNIS Eyhance Optiblue in combined vitrectomy and cataract surgery in patients with ERM
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes distance visual acuity, intermediate visual acuity
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patients who receive combined vitrectomy and cataract surgery in patients with ERM.
Key exclusion criteria The patients who have other diseases except for cataract and ERM
Target sample size 140

Research contact person
Name of lead principal investigator
1st name Hiroki
Middle name
Last name Kaneko
Organization Nagoya University
Division name Department of Ophthalmology
Zip code 466-8550
Address 65 Tsurumai, Showa-ku, Nagoya
TEL 0527442275
Email h-kaneko@med.nagoya-u.ac.jp

Public contact
Name of contact person
1st name Hiroki
Middle name
Last name Kaneko
Organization Nagoya University
Division name Department of Ophthalmology
Zip code 466-8550
Address 65 Tsurumai, Showa-ku, Nagoya
TEL 052-744-2277
Homepage URL
Email h-kaneko@med.nagoya-u.ac.jp

Sponsor
Institute Department of Ophthalmology, Nagoya University
Institute
Department

Funding Source
Organization Department of Ophthalmology, Nagoya University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Department of Ophthalmology, Nagoya University
Address 65 Tsurumai-cho, Showa-ku, Nagoya
Tel 052-744-2277
Email h-kaneko@med.nagoya-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 名古屋大学医学部附属病院(愛知県)、医療法人湘山会眼科三宅病院(愛知県)、西尾市民病院(愛知県)、医療法人豊田会刈谷豊田総合病院(愛知県)、一宮市立市民病院(愛知県)

Other administrative information
Date of disclosure of the study information
2022 Year 05 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2022 Year 03 Month 11 Day
Date of IRB
2022 Year 06 Month 14 Day
Anticipated trial start date
2022 Year 05 Month 01 Day
Last follow-up date
2024 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Observational study

Management information
Registered date
2022 Year 03 Month 17 Day
Last modified on
2022 Year 06 Month 29 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053842